PT83872B - Processo de preparacao de compostos de fosforo e de medicamentos contendo-os - Google Patents

Processo de preparacao de compostos de fosforo e de medicamentos contendo-os

Info

Publication number
PT83872B
PT83872B PT83872A PT8387286A PT83872B PT 83872 B PT83872 B PT 83872B PT 83872 A PT83872 A PT 83872A PT 8387286 A PT8387286 A PT 8387286A PT 83872 B PT83872 B PT 83872B
Authority
PT
Portugal
Prior art keywords
pct
preparation
phosphorus compounds
medicines containing
sec
Prior art date
Application number
PT83872A
Other languages
English (en)
Other versions
PT83872A (de
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of PT83872A publication Critical patent/PT83872A/pt
Publication of PT83872B publication Critical patent/PT83872B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT83872A 1985-12-04 1986-12-04 Processo de preparacao de compostos de fosforo e de medicamentos contendo-os PT83872B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3542893 1985-12-04
DE3606631 1986-02-28

Publications (2)

Publication Number Publication Date
PT83872A PT83872A (de) 1987-01-01
PT83872B true PT83872B (pt) 1989-01-17

Family

ID=25838509

Family Applications (2)

Application Number Title Priority Date Filing Date
PT83872A PT83872B (pt) 1985-12-04 1986-12-04 Processo de preparacao de compostos de fosforo e de medicamentos contendo-os
PT83873A PT83873B (pt) 1985-12-04 1986-12-04 Processo de preparacao de medicamentos contendo hexadecilfosfocolina

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT83873A PT83873B (pt) 1985-12-04 1986-12-04 Processo de preparacao de medicamentos contendo hexadecilfosfocolina

Country Status (15)

Country Link
US (2) US4837023A (pt)
EP (4) EP0225608A3 (pt)
JP (2) JPH0637393B2 (pt)
AT (2) ATE75608T1 (pt)
CA (2) CA1338627C (pt)
DE (4) DE3679908D1 (pt)
DK (2) DK172954B1 (pt)
ES (2) ES2038215T3 (pt)
FI (2) FI873364A (pt)
GR (2) GR3002487T3 (pt)
HU (2) HU208143B (pt)
IE (2) IE59777B1 (pt)
NO (2) NO174877C (pt)
PT (2) PT83872B (pt)
WO (2) WO1987003478A2 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
ES2086395T3 (es) * 1989-08-10 1996-07-01 Sandoz Ltd Fosfolipidos para el tratamiento de esclerosis multiple.
US5182271A (en) * 1989-08-10 1993-01-26 Sandoz Ltd. Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
EP0419998A3 (en) * 1989-09-27 1991-10-23 Asta Pharma Aktiengesellschaft Use of alkylphosphonic acid derivatives for the treatment of psoriasis
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5506217A (en) * 1991-04-25 1996-04-09 The University Of British Columbia Phosphonates as anti-cancer agents
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
ATE158295T1 (de) * 1991-07-04 1997-10-15 Asta Medica Ag Verfahren zur herstellung von alkylphosphocholinen und reinherstellung derselben
US6254879B1 (en) 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
AU7044894A (en) * 1993-06-10 1995-01-03 University Of North Carolina At Chapel Hill, The (phospho)lipids for combatting hepatitis b virus infection
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
WO1995007089A1 (en) 1993-09-09 1995-03-16 Imutec Corporation Immunomodulating compositions from bile
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5962437A (en) * 1994-08-29 1999-10-05 Wake Forest University Lipid analogs for treating viral infections
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
WO1996024598A1 (en) * 1995-02-10 1996-08-15 The University Of British Columbia [4-hexadecyl-3-methoxy-butyl] phosphonic acid and its protein conjugates useful as anti-cancer agents
AU711294B2 (en) 1995-03-16 1999-10-07 Erin Mills Biotech Inc. Immunomodulating compositions from bile for the treatment of immune system disorders
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
SE9701912D0 (sv) * 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US7582678B2 (en) * 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
ATE215817T1 (de) * 1998-01-22 2002-04-15 Zentaris Ag Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
IL137672A0 (en) 2000-08-03 2001-10-31 Dpharm Ltd Derivatives of branched-chain lipophilic molecules and uses thereof
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
US6960738B2 (en) * 2001-05-29 2005-11-01 Koninklijke Philips Electronics N.V. Metal-ceramic bond
JP4714413B2 (ja) * 2001-08-31 2011-06-29 トムソン ライセンシング オーディオビジュアルストリームのためのシーケンスカウンタ
AU2002346284A1 (en) * 2002-04-26 2003-11-10 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
PL1962862T3 (pl) 2005-12-19 2014-01-31 Aeterna Zentaris Gmbh Pochodne alkilofosfolipidów o ograniczonej cytotoksyczności i ich zastosowania
WO2008074573A1 (en) * 2006-12-20 2008-06-26 Alphaptose Gmbh Topical dosage form comprising tri-substituted glycerol compounds
JP2011057647A (ja) * 2009-09-14 2011-03-24 Adeka Corp 化粧料
KR102055395B1 (ko) 2011-06-24 2019-12-12 쥐알아이 바이오,아이엔씨. 염증 질환의 예방 및 치료
CN102491994B (zh) * 2011-12-07 2014-10-15 宁波九胜创新医药科技有限公司 一种胆碱磷酸烷基酯的制备方法
CA3007970A1 (en) * 2014-12-09 2016-06-16 Gri Bio, Inc. Prevention and treatment of inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds

Also Published As

Publication number Publication date
WO1987003480A3 (fr) 1988-02-25
DE3641491A1 (de) 1987-09-17
CA1338627C (en) 1996-10-01
IE863177L (en) 1987-06-04
US4837023A (en) 1989-06-06
PT83873A (de) 1987-01-01
EP0225608A2 (de) 1987-06-16
FI873363A (fi) 1987-08-03
IE59777B1 (en) 1994-04-06
EP0230575A3 (de) 1987-12-02
ATE75608T1 (de) 1992-05-15
GR3002487T3 (en) 1992-12-30
JPH0637393B2 (ja) 1994-05-18
JPH0859677A (ja) 1996-03-05
ES2038215T3 (es) 1993-07-16
WO1987003478A2 (fr) 1987-06-18
DE19375061I2 (de) 2008-11-20
NO873244D0 (no) 1987-08-03
HUT44441A (en) 1988-03-28
DK398587D0 (da) 1987-07-30
DE3679908D1 (de) 1991-07-25
DE3641379A1 (de) 1987-09-03
IE863176L (en) 1987-06-04
IE59778B1 (en) 1994-04-06
DK398587A (da) 1987-07-30
HU203201B (en) 1991-06-28
FI873364A0 (fi) 1987-08-03
NO873243D0 (no) 1987-08-03
JPS63501719A (ja) 1988-07-14
EP0248062A1 (de) 1987-12-09
NO175620C (no) 1994-11-09
PT83873B (pt) 1989-01-17
DK393187D0 (da) 1987-07-28
HU208143B (en) 1993-08-30
EP0248047B1 (de) 1991-06-19
EP0225608A3 (de) 1987-10-28
EP0230575A2 (de) 1987-08-05
PT83872A (de) 1987-01-01
GR3005168T3 (pt) 1993-05-24
NO873244L (no) 1987-10-01
NO175620B (pt) 1994-08-01
NO174877C (no) 1994-07-27
CA1280369C (en) 1991-02-19
US5049552A (en) 1991-09-17
JP2857084B2 (ja) 1999-02-10
FI873363A0 (fi) 1987-08-03
HUT44431A (en) 1988-03-28
WO1987003480A2 (en) 1987-06-18
EP0248062B1 (de) 1992-05-06
ES2032755T3 (es) 1993-03-01
WO1987003478A3 (fr) 1987-09-24
DK393187A (da) 1987-07-28
ATE64529T1 (de) 1991-07-15
EP0248047A1 (de) 1987-12-09
FI873364A (fi) 1987-08-03
DK172954B1 (da) 1999-10-18
NO174877B (no) 1994-04-18
NO873243L (no) 1987-10-02

Similar Documents

Publication Publication Date Title
PT83872B (pt) Processo de preparacao de compostos de fosforo e de medicamentos contendo-os
GR852492B (pt)
BR8606336A (pt) Derivados de pirazolina,processo para sua preparacao,composicoes inseticidas e emprego
HUT41800A (en) Process for producing new beta-lactame antibiotica and pharmaceutical compositions containing them as active agents
ES8503643A1 (es) Un procedimiento para la preparacion de compuestos de bis (carboxamida)
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
ES2016376B3 (es) Acido n,n-bis-(4-fluorofenil) carbamoilacetohidroxamico y composicion farmaceutica que lo contiene.
IT8522357A0 (it) Processo per la preparazione dicomposti carbonilici otticamente attivi.
PT82117B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 3-ariloxiazetidinocarboxamidas utilizaveis como agentes anticonvulsivantes e antiepilepticos
DE3877747T2 (de) Glasartige matrize zur verabreichung von heilmitteln.
IL84213A (en) N-acylated derivatives of bisanthrene,process for their preparation and pharmaceutical compositions containing them
ATE41418T1 (de) S-(carbamoyl-phenylselenyl)-derivate des glutathions und von aminomercaptocarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
PT83874B (pt) Processo de preparacao de compostos de fosforo e de medicamentos contendo os mesmos
OA08184A (fr) Agents anti-hypertentifs, compositions pharmaceutiques les contenant et procédé de préparation desdits agents et compositions.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20041220